◄ back to all posts
Financial data and stock pages provided by
Fintel.io
◄ back to all posts
EBS: Emergent Biosolutions, Inc. Stock
Written by | Jul 6, 2018
Print FriendlySIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 5,833.09 |
| Enterprise Value ($M) | 6,224.02 |
| Book Value ($M) | 1,251.50 |
| Book Value / Share | 23.61 |
| Price / Book | 4.57 |
| NCAV ($M) | -406.00 |
| NCAV / Share | -7.66 |
| Price / NCAV | -14.37 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.03 |
| Return on Assets (ROA) | 0.02 |
| Return on Equity (ROE) | 0.05 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.30 |
| Current Ratio | 3.20 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 958.80 |
| Assets | 2,616.30 |
| Liabilities | 1,364.80 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 114.10 |
| Net Income | 54.50 |
| Earnings Per Share Diluted | 1.04 |
| Earnings Per Share Basic | 1.06 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 188.00 |
| Cash from Investing | -96.90 |
| Cash from Financing | -96.90 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vanguard Group Inc | 9.04 | -3.42 | |
| 13G/A | BlackRock Inc. | 13.20 | 3.96 | |
| 13G/A | Dimensional Fund Advisors Lp | 3.32 | -24.79 | |
| 13G/A | Broadfin Capital, LLC | 1.70 | ||
| 13G/A | Bank of New York Mellon Corp | 4.81 | 274.63 | |
| 13G/A | Loomis Sayles & Co L P | 2.20 | ||
| 13G/A | Scopia Capital Management Lp | 0.00 | ||
| 13G/A | Royce & Associates Lp | 0.37 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| Quarterly Report – 10-Q | ||
| Quarterly Report – 10-Q | ||
| Quarterly Report – 10-Q | ||
| Annual Report – 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 93,159 | 500,900 | 18.60 | |
| 53,079 | 513,200 | 10.34 | |
| 64,687 | 474,000 | 13.65 | |
(click for more detail) |
|||
(click for list of largest short owners) |
|||
| Similar Companies | |
|---|---|
| BXLT – Baxalta Incorporated | CBM – Cambrex Corp. |
| CTLT – Catalent Inc. | ELAN – Elanco Animal Health Inc |
| FRX – Forest Laboratories Inc |
Financial data and stock pages provided by
Fintel.io
2018/07/06
